Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety
- 16 March 2020
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 353 (5) , e2000002
Abstract
A series of new nitroimidazole‐containing derivatives was synthesized by coupling of 2‐[2‐(2‐methyl‐5‐nitro‐1H‐imidazol‐1‐yl)ethylthio]ethanol with diversely substituted benzoic acids. Upon treatment with m‐CPBA, 12 of these sulfanyl compounds were further oxidized to their sulfonyl analogs. All the 26 synthetic compounds were examined for in vitro activity against Leishmania (V.) braziliensis and Leishmania (L.) mexicana, and some of them displayed an efficient antileishmanial activity. Among the compounds tested, the catecholic derivative 2‐{[2‐(2‐methyl‐5‐nitro‐1H‐imidazol‐1‐yl)ethyl]sulfanyl}ethyl 3,4‐dihydroxybenzoate (9a, LC50 = 13 and 11 µM) and the pyrogallolic derivative 2‐{[2‐(2‐methyl‐5‐nitro‐1H‐imidazol‐1‐yl)ethyl]sulfanyl}ethyl 3,4,5‐trihydroxybenzoate (9b, LC50 = 4 and 1 µM) were the most active ones against the two Leishmania strains.Keywords
Funding Information
- Université de Bordeaux
- Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
- Centre National de la Recherche Scientifique
This publication has 30 references indexed in Scilit:
- In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania speciesJournal of Antimicrobial Chemotherapy, 2019
- Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in LeishmaniasisCurrent Drug Metabolism, 2016
- Antileishmanial drug discovery: comprehensive review of the last 10 yearsRSC Advances, 2015
- N -Butyl-[1-(4-Methoxy)Phenyl-9 H -β-Carboline]-3-Carboxamide Prevents Cytokinesis in Leishmania amazonensisAntimicrobial Agents and Chemotherapy, 2014
- Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistanceParasite, 2011
- Synthesis and Antileishmanial activity of Piperoyl-Amino Acid ConjugatesEuropean Journal of Medicinal Chemistry, 2010
- Transient effect of topical treatment of cutaneous leishmaniasis with imiquimodInternational Journal of Dermatology, 2003
- Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.The American Journal of Tropical Medicine and Hygiene, 2001
- Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral LeishmaniasesAntimicrobial Agents and Chemotherapy, 1999
- The antileishmanial activity of novel oxygenated chalcones and their mechanism of actionJournal of Antimicrobial Chemotherapy, 1999